| ¿µ¹® | development | ÇÑ±Û | ¹ß´Þ, ¹ß»ý, ¹ßÀ° |
|---|---|---|---|
| ¼³¸í | 1. ¹ß´Þ. ½É½ÅÀÇ ÇüÅÂ¿Í Àç´ÉÀÇ »ó½ÂÀûÀÎ º¯È°úÁ¤. ¼ºÀå°ú ¸Å¿ì À¯»çÇÑ °³³äÀ¸·Î, ¶§·Î´Â °°Àº ¶æÀ¸·Î ¾²ÀÌ´Â °æ¿ìµµ ÀÖ´Ù. ±×·¯³ª ¼ºÀåÀº °³Ã¼ÀÇ ¹ßÀ°¿¡ µû¸£´Â º¯È, Áï °è¿ÀûÀ¸·Î ¾çÀûÀÎ Áõ°¡·Î¼ ±â¼úÇÏ´Â °æ¿ì¿¡ ¸¹ÀÌ ¾²À̰í, ¹ß´ÞÀº ÀÌ¿Í °°Àº º¯È¸¦ ¾çÀûÀÎ ¸é»Ó¸¸ ¾Æ´Ï¶ó, ±¸Á¶³ª Àç´ÉÀÌ ºÐÈ-º¹ÀâÈ-Á¤¹ÐÈ-À¯´ÉÈ-ÅëÇÕÈµÇ¾î °¡´Â °ÍÀ¸·Î¼ ±â¼úÇÏ´Â °æ¿ì¿¡ ´õ¿í ¸¹ÀÌ ¾²ÀÌ´Â °æÇâÀÌ ÀÖ´Ù. ±×¸®°í ¹ß´ÞÀ̶ó°í ÇÏ´Â °³³äÀº, À¯±âüÀÇ ¹ßÀ°¿¡ ´ëÇØ¼¸¸ ¾²ÀÌ´Â °ÍÀÌ ¾Æ´Ï¶ó, ¹«»ý¹°À̳ª ¹°¸®Àû-ÈÇÐÀû Çö»ó¿¡ ´ëÇØ¼µµ ¶Ç´Â »çȸÀû-¹®ÈÀû Çö»ó¿¡ ´ëÇØ¼µµ ½Ã°£Àû º¯È¹ßÀüÀ» ¼ö¹ÝÇÏ´Â °æ¿ì¿¡ Àû¿ëµÇ´Â °³³äÀÌ´Ù. 2. ¹ßÀ°. ¹ßÀ°°úÁ¤¿¡´Â ´ÙÀ½°ú °°Àº ÀϹÝÀûÀÎ ¿øÄ¢À» º¸ÀδÙ. ¨ç ¹ßÀ°Àº Áú¼Á¤¿¬ÇÏ°Ô ÀÏÁ¤ÇÑ ¼ø¼¸¦ °®´Â´Ù. ¨è ¹ßÀ°Àº ¿¬¼ÓÀûÀ̳ª ÀÏÁ¤ÇÑ ¼Óµµ·Î ÁøÇàÇÏ´Â °ÍÀº ¾Æ´Ï´Ù. ¨é ¹ßÀ°¿¡´Â ¹ßÀ°»ó Áß¿äÇÑ °¨¼ö±â¿Í ÀÓ°è±â°¡ ÀÖ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| ¿µ¹® | neonatal intensive care center | ÇÑ±Û | ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç |
|---|---|---|---|
| ¼³¸í | ¹Ì¼÷¾Æ³ª °¡»ç »óÅÂÀÇ Ãâ»ê¾Æ¸¦ ÁýÁßÀûÀ¸·Î º¸»ìÇǰí Ä¡·áÇÏ´Â ±â°ü. |
||
| ¿µ¹® | intensive care unit | ÇÑ±Û | ÁßȯÀÚ½Ç |
|---|---|---|---|
| ¼³¸í | º´¼¼³ª »óó µûÀ§ÀÇ Á¤µµ°¡ ¸Å¿ì ½ÉÇÑ »ç¶÷À» Ä¡·áÇÏ°í µ¹º¼ ¼ö ÀÖµµ·Ï ¸¶·ÃÇÑ ¹æ. È£Èí-¼øÈ¯-´ë»ç µî Á¤½ÅÀû ±Þ¼º±â´É»ó½ÇÀÇ È¯ÀÚ¸¦ Ãë±ÞÇÏ¸ç °·ÂÇÏ°íµµ ÁýÁßÀûÀÎ Áø·á¸¦ ÇÏ´Â ºÎºÐÀÌ´Ù. À§µ¶ÇÑ È¯ÀÚ¿¡ ´ëÇÏ¿©´Â 24½Ã°£ üÁ¦·Î ´ëÀÀÇÑ´Ù. ÃæºÐÈ÷ ÈÆ·ÃÀ» ¹ÞÀº ÀÇ·áÁøÀÌ ¹èÄ¡µÇ¸ç ±â´ÉÀûÀ¸·Î ¼³ºñ°¡ °®Ãß¾îÁ® ÀÖ´Ù. ½É±Ù°æ»öÁõ-È£Èí±â´É»ó½Ç-ÄáÆÏ±â´É»ó½Ç-¼Ò¾Æ-½Å°æ¿Ü°ú°è µî ƯÁ¤È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ´Ù. |
||
| ¿µ¹® | health | ÇÑ±Û | °Ç° |
|---|---|---|---|
| ¼³¸í | ½ÅüÀû-Á¤½ÅÀûÀ¸·Î º´ÀÌ ¾ø´Â »óÅÂ. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ÇåÀå¿¡´Â ¡°°Ç°À̶õ Áúº´ÀÌ ¾ø°Å³ª Çã¾àÇÏÁö ¾ÊÀº °Í¸¸ ¸»ÇÏ´Â °ÍÀÌ ¾Æ´Ï¶ó ½ÅüÀû-Á¤½ÅÀû-»çȸÀûÀ¸·Î ¿ÏÀüÈ÷ ¾È³çÇÑ »óÅ¿¡ ³õ¿© ÀÖ´Â °Í¡±À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. »ç¶÷Àº ÀÎÁ¾-Á¾±³-Á¤Ä¡-°æÁ¦-»çȸÀÇ »óÅ ¿©Çϸ¦ ºÒ¹®ÇÏ°í °íµµÀÇ °Ç°À» ´©¸± ±Ç¸®°¡ ÀÖ´Ù´Â °ÍÀ» ¸í½ÃÇÑ °ÍÀÌ´Ù. Áï °ú°Å¿¡´Â, °Ç°À̶õ À°Ã¼Àû-Á¤½ÅÀûÀ¸·Î Áúº´À̳ª ÀÌ»óÀÌ ¾ø°í, °³ÀÎÀûÀ¸·Î Á¤»óÀûÀÎ »ýȰÀ» ¿µÀ§ÇÒ ¼ö ÀÖ´Â ½Åü»óŸ¦ ¸»ÇÏ¿´À¸³ª, ¿À´Ã³¯¿¡´Â °³ÀÎÀÌ »çȸ»ýȰ¿¡ ÀÇÁ¸ÇÏ´Â °æÇâÀÌ Ä¿Áü¿¡ µû¶ó¼ »çȸ°¡ °¢ °³ÀÎÀÇ °Ç°¿¡ ±â´ëÇÏ´Â °Íµµ ¸¹¾ÆÁ³±â ¶§¹®¿¡ »çȸÀûÀÎ °Ç°À̶õ ¸é¿¡¼ ÀÌ¿Í °°Àº Á¤Àǰ¡ »ý°Ü³ °ÍÀ¸·Î º¸ÀδÙ. Çѱ¹ÀÇ Çå¹ý¿¡´Â °Ç°À» ¡°¸ðµç ±¹¹ÎÀÌ ¸¶¶¥È÷ ´©·Á¾ß ÇÒ ±âº»ÀûÀÎ ±Ç¸®¡±¶ó°í ±ÔÁ¤Çϰí ÀÖ¾î °Ç°À» ÇϳªÀÇ ±âº»±ÇÀû °³³äÀ¸·Î º¸°í ÀÖ´Ù. ¶ÇÇÑ Áúº´ÀÌ ¾ø´Â »óŶó´Â ¼öµ¿Àû °Ç°¿¡ ´ëÇÑ Åµµ¿¡¼, ±ÝÁÖ-±Ý¿¬ µî »ýȰ½À°üÀÇ º¯È³ª ¿îµ¿ °°Àº Àû±ØÀûÀ¸·Î °Ç°ÇØÁö·Á´Â ³ë·Â µî ´Éµ¿Àû ŵµ°¡ °Á¶µÇ°í ÀÖ´Ù. °Ç°ÀÇ ±¸Ã¼Àû ¿ä¼Ò·Î´Â À°Ã¼ÀûÀÎ ÇüÅÂÀû ¿ä¼Ò(½ÅÀå-üÁß°ú °°Àº ¿ÜÇüÀû °èÃø°ªÀ̳ª ³»ÀåÀÇ ¿©·¯ ±â°ü µî)¿Í ±â´ÉÀû ¿ä¼Ò(¿©·¯ ±â°üÀÇ »ý¸®±â´ÉÀ̳ª Á¾ÇÕÀûÀΠü·Â µî), Á¤½Å±â´ÉÀû ¿ä¼Ò·Î ºÐ·ùÇÏ¿© Æò°¡Çϱ⵵ ÇÑ´Ù. |
||
| CCC | care-cure coordination; cathodal closure contraction; chronic calculous cholecystitis; chronic catar... |
|---|---|
| PCA | para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant... |
| PCC | Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl... |
| CHARGE | coloboma, heart disease, atresia choanae, retarded growth and retarded development and/or CNS anomal... |
| MHP | hemiplegic migraine; maternal health program; maternal health program; medical center health plan; 1... |
| NICHD | National Institute of Child Health and Human Development |
|---|---|
| AHCPR | Agency for Health Care Policy and Research |
| AHRQ | Agency for Health Care Research and Quality |
| HUD | Housing and Urban Development |
| MGDF | Megakaryocyte Growth and Development Factor |
| state health planning and development agencies | Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council. (12 Dec 1998) |
|---|---|
| health care economics and organizations | The economic aspects of health care, its planning, and delivery. It includes government agencies and organizations in the private sector. (12 Dec 1998) |
| health care facilities, manpower, and services | The services provided in the delivery of health care, associated facilities in health care, and attendant manpower required or available. (12 Dec 1998) |
| health care quality, access, and evaluation | The concept concerned with all aspects of the quality, accessibility, and appraisal of health care and health care delivery. (12 Dec 1998) |
| united states agency for health care policy and research | An agency of the public health service established in 1990 to "provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery.." it supersedes the national centre for health services research. (12 Dec 1998) |
| growth and embryonic development | Developmental processes from cell division to embryogenesis to postnatal growth and maturity. (12 Dec 1998) |
| land conservation and development commission | (LCDC) A commission appointed to determine land use policy in Oregon. (05 Dec 1998) |
| care proxy, health | A health care proxy is one form of advance medical directive. Advance medical directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There are two basic forms of advance directives: 1. A living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers. 2. A health care proxy (also called a power of attorney for health-care decision-making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (This entry is based upon material from the National MS Society). (12 Dec 1998) |
| patient acceptance of health care | The seeking and acceptance by patients of health service. (12 Dec 1998) |
| peer review, health care | The concurrent or retrospective review by practicing physicians or other health professionals of the quality and efficiency of patient care practices or services ordered or performed by other physicians or other health professionals . (12 Dec 1998) |
| comprehensive health care | Providing for the full range of personal health services for diagnosis, treatment, follow-up and rehabilitation of patients. (12 Dec 1998) |
| health care | Services provided to individuals or communities by agents of the health services or professions for the purpose of promoting, maintaining, monitoring, or restoring health. (05 Mar 2000) |
| health care coalitions | Voluntary groups of people representing diverse interests in the community such as hospitals, businesses, physicians, and insurers, with the principal objective to improve health care cost effectiveness. (12 Dec 1998) |
| health care costs | The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from health expenditures, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost. (12 Dec 1998) |
| health care evaluation mechanisms | Methods and techniques used in evaluating the quality of health care, its planning, and delivery. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|